Heart-Healthy Benefits of Astragalus
Astragalus contains many compounds with antioxidant and anti-inflammatory properties. Preclinical studies suggest they may help keep your heart healthy by:
- Improving cholesterol levels.(5)
- Reducing plaque in arteries.(5)
- Lowering high blood pressure.(10)
- Decreasing high homocysteine levels.(166)
Evidence of Benefit
The benefits of astragalus and its compounds in cardiovascular disease mostly comes from lab and animal research. However, there have been some small clinical trials. These include:
Trial Details | Results |
---|---|
12-month clinical study.(54) 154 women past menopause with metabolic syndrome (including high blood pressure) randomly divided into 3 groups:(54)
|
Higher doses of astragalus significantly improved function in the left ventricle of the heart compared to control group.(54) |
12-month clinical study.(167) 119 patients with hypertension and metabolic syndrome, randomly divided in 3 groups:(167)
|
Small doses of astragalus over the long term (at least a year) may protect kidneys and arteries from damage caused by high blood pressure.(167) |
2-week clinical study.(168) 122 elderly patients with hypertension, randomly divided in 2 groups:(168)
|
Astragalus significantly improved 2 important indicators of damage in the arteries of elderly people with high blood pressure.(168, 169) |
12-month clinical study.(170) 206 patients ages 18-60 years old with hypertension and metabolic syndrome, randomly divided in 3 groups:(170)
|
In women, astragalus intake was linked to significantly better results in:(170)
Total cholesterol and one indicator of arterial disease improved in men. Interestingly the protective effect of astragalus was better in female patients.(170) |
10 to 20-day clinical study.(171) 190 patients with unstable angina, randomly divided in 3 groups:(171)
|
At the higher dosage, astragalus:(171)
Results showed astragalus was more effective than conventional treatment by itself (or with placebo).(171) |
28-week double-blind, randomized, controlled, crossover clinical study.(172) 40 patients with metabolic syndrome, randomly divided in 2 groups:(172)
After a 3-week period with no treatment (washout period), the groups' treatments were switched for another 12 weeks.(172) |
Compared to when patients were taking placebo, the astragalus compound showed the following beneficial cardiovascular effects:(172)
|